Published in Diagn Cytopathol on February 01, 2004
The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (2007) 49.11
The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol (2002) 8.62
The genetic landscape of the childhood cancer medulloblastoma. Science (2010) 8.34
The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol (2009) 6.79
A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma. Clin Cancer Res (2009) 5.99
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol (2006) 4.72
The Bethesda System for Reporting Thyroid Cytopathology. Thyroid (2009) 4.48
An immune-active tumor microenvironment favors clinical response to ipilimumab. Cancer Immunol Immunother (2011) 4.02
ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov (2011) 3.27
Spontaneous pneumomediastinum: a comparative study and review of the literature. Ann Thorac Surg (2008) 3.25
Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. Cancer (2002) 3.23
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol (2004) 3.10
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma. J Transl Med (2011) 2.86
Autoimmune hypophysitis. Endocr Rev (2005) 2.86
Monomorphous angiocentric glioma: a distinctive epileptogenic neoplasm with features of infiltrating astrocytoma and ependymoma. J Neuropathol Exp Neurol (2005) 2.58
Fine-needle aspiration of renal cell carcinoma: is accurate Fuhrman grading possible on cytologic material? Diagn Cytopathol (2011) 2.57
Development of ipilimumab: contribution to a new paradigm for cancer immunotherapy. Semin Oncol (2010) 2.51
Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res (2002) 2.41
Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. J Neuropathol Exp Neurol (2008) 2.40
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro Oncol (2011) 2.39
Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol (2003) 2.37
Angiocentric glioma: a case series. J Neurosurg Pediatr (2009) 2.21
Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma. Cancer (2004) 2.11
Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance. J Neuropathol Exp Neurol (2004) 1.85
Pre-processing Agilent microarray data. BMC Bioinformatics (2007) 1.84
High-grade astrocytoma in very young children. Pediatr Blood Cancer (2007) 1.77
Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery (2008) 1.72
Pathologist interobserver variability of histologic features in childhood brain tumors: results from the CCG-945 study. Pediatr Dev Pathol (2007) 1.70
"Parapharyngeal space" tumors: a cytopathological study of 24 cases on fine-needle aspiration. Diagn Cytopathol (2005) 1.67
The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience. Neuro Oncol (2003) 1.66
c-myc overexpression causes anaplasia in medulloblastoma. Cancer Res (2006) 1.66
Primary Intraosseous Skull Base Cavernous Hemangioma: Case Report. Skull Base (2003) 1.63
Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. J Neuropathol Exp Neurol (2004) 1.62
BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants. J Neuropathol Exp Neurol (2012) 1.60
The cytopathology of malignant peripheral nerve sheath tumor: a report of 55 fine-needle aspiration cases. Cancer Cytopathol (2012) 1.56
Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer (2008) 1.56
Primary pancreatic lymphomas: a cytopathologic analysis of a rare malignancy. Cancer (2004) 1.54
A virus causes cancer by inducing massive chromosomal instability through cell fusion. Curr Biol (2007) 1.51
Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets. Blood (2003) 1.49
Orthogonal polarization spectroscopy to detect mesenteric hypoperfusion. Intensive Care Med (2008) 1.48
Pilocytic and pilomyxoid hypothalamic/chiasmatic astrocytomas. Neurosurgery (2004) 1.47
Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402. Brain Pathol (2008) 1.46
Defining future directions in spinal cord tumor research: proceedings from the National Institutes of Health workshop. J Neurosurg Spine (2010) 1.45
Astroblastoma: radiologic-pathologic correlation and distinction from ependymoma. AJNR Am J Neuroradiol (2002) 1.44
Hepatocyte paraffin 1 immunoexpression in esophageal brush samples. Cancer (2005) 1.44
Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendroglioma. Arch Pathol Lab Med (2007) 1.43
Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients. Clin Cancer Res (2005) 1.40
Impact of flow cytometry in thyroid cytopathology. Acta Cytol (2013) 1.40
IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group. Childs Nerv Syst (2010) 1.39
The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors. Mod Pathol (2007) 1.38
MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group. Arch Pathol Lab Med (2002) 1.37
Cytopathologic features of mammary analogue secretory carcinoma. Cancer Cytopathol (2012) 1.37
Malignant peripheral nerve sheath tumors of cranial nerves and intracranial contents: a clinicopathologic study of 17 cases. Am J Surg Pathol (2009) 1.36
A systematic review of solid-pseudopapillary neoplasms: are these rare lesions? Pancreas (2014) 1.35
Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial. Melanoma Res (2011) 1.35
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors. Cancer (2005) 1.34
Atypical teratoid/rhabdoid tumor of the brain: cytopathologic characteristics and differential diagnosis. Cancer (2005) 1.33
Use of personalized molecular biomarkers in the clinical care of adults with glioblastomas. J Neurooncol (2012) 1.32
Solitary fibrous tumors in the central nervous system. A clinicopathologic review of 18 cases and comparison to meningeal hemangiopericytomas. Arch Pathol Lab Med (2003) 1.29
Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev (2008) 1.25
Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors. Am J Surg Pathol (2010) 1.23
Embryonal tumors with abundant neuropil and true rosettes: a distinctive CNS primitive neuroectodermal tumor. Am J Surg Pathol (2009) 1.23
Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features. J Neuropathol Exp Neurol (2003) 1.18
Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases. Brain Pathol (2008) 1.18
INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. J Neuropathol Exp Neurol (2005) 1.17
Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: a primary low-grade CNS lymphoma that mimics meningioma. J Clin Oncol (2005) 1.17
Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study. J Clin Oncol (2012) 1.17
Malignant solitary fibrous tumor: cytopathologic findings and differential diagnosis. Cancer Cytopathol (2010) 1.16
Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myeloma. Br J Haematol (2010) 1.14
Ipilimumab increases activated T cells and enhances humoral immunity in patients with advanced melanoma. J Immunother (2012) 1.14
HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res (2003) 1.13
Inflammatory myofibroblastic tumor of the central nervous system and its relationship to inflammatory pseudotumor. Hum Pathol (2008) 1.13
Anaplasia in pilocytic astrocytoma predicts aggressive behavior. Am J Surg Pathol (2010) 1.13
Time trends in oligodendroglial and astrocytic tumor incidence. Neuroepidemiology (2008) 1.12
Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 study. Br J Haematol (2011) 1.12
Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children's Oncology Group. Neurosurgery (2011) 1.12
Deep fibromatosis (desmoid tumor): cytopathologic characteristics, clinicoradiologic features, and immunohistochemical findings on fine-needle aspiration. Cancer (2007) 1.11
hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors. Am J Pathol (2003) 1.11
MR imaging characteristics of pilomyxoid astrocytomas. AJNR Am J Neuroradiol (2003) 1.10
Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J (2012) 1.09
Cytopathology of alveolar soft part sarcoma: a report of 10 cases. Cancer (2009) 1.09
Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol (2012) 1.09
Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol (2002) 1.08
Phase 2 study of idarubicin in pediatric brain tumors: Pediatric Oncology Group study POG 9237. Neuro Oncol (2003) 1.07
Tanespimycin monotherapy in relapsed multiple myeloma: results of a phase 1 dose-escalation study. Br J Haematol (2010) 1.07
Imaging findings of CNS atypical teratoid/rhabdoid tumors. AJNR Am J Neuroradiol (2004) 1.06
Ependymomas with neuronal differentiation: a morphologic and immunohistochemical spectrum. Acta Neuropathol (2006) 1.06
Pineal gland lesions: a cytopathologic study of 20 specimens. Cancer (2005) 1.06
Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories. Int J Cancer (2005) 1.05
Primary anaplastic large cell lymphoma of the central nervous system: prognostic effect of ALK-1 expression. Am J Surg Pathol (2003) 1.04
Induction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma: Children's Oncology Group study P9934. J Clin Oncol (2012) 1.03
Pilomyxoid astrocytoma: a review. MedGenMed (2004) 1.02
Molecular diagnosis of oligodendroglioma in paraffin sections. Lab Invest (2003) 1.02
Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer. Clin Cancer Res (2006) 1.01
Fine-needle aspiration of intrapancreatic accessory spleen: cytomorphologic features and differential diagnosis. Cancer Cytopathol (2012) 1.01
The Bethesda System for reporting thyroid fine-needle aspiration specimens. Am J Clin Pathol (2010) 1.00
Anaplasia and grading in medulloblastomas. Brain Pathol (2003) 1.00